BSX

Boston Scientific Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth 7/10
  • Value 1/10
Boston Scientific sales and earnings growth
BSX Growth
Good
  • Revenue Y/Y 19.87%
  • EPS Y/Y 55.56%
  • FCF Y/Y 38.30%
Boston Scientific gross and profit margin trends
BSX Profitability
Great
  • Gross margin 69.00%
  • EPS margin 14.40%
  • ROIC 5Y 13.32%
Boston Scientific net debt vs free cash flow
BSX Risk
Great
  • Debt / Equity 0.5
  • Debt / FCF 2.6
  • Interest coverage 10.7

Boston Scientific stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗